17 April, PharmAust and WEHI evaluate monepantel for COVID-19 in vitro
200417_Monepantel in SARS-CoV-2
31 March, Top 20 Shareholders
200401_Top_Holders
31 March, Expiry of Options
200313_Expiry of Options
31 March, Phase II Trial Update
200313_Phase II Dog Trial Update
3 March, Brisbane Animal Referral Hospital Joins PharmAust Phase II Dog Cancer Trial
200403_Expansion of Sites
29 February, Top 20 Shareholders
200229_Top_Holders_Movements_Report
28 Feb, Appendix 4D & Half Year Report
200228_Appendix 4D & Half Year Report
31 January 2020, Top 20 Shareholders
200203_Top_Holders_Report
28 January, Appendix 4C and Quarterly Update
200128_Appendix 4C and Quarterly Update
$700K R&D Tax Incentive Refund.
200114_$700K R&D Tax Incentive Refund